{"id":"W2624246814","doi":"10.1097/spc.0000000000000277","title":"Current management of metastatic renal cell carcinoma: evolving new therapies","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Pazopanib; Temsirolimus; Cabozantinib; Axitinib; Lenvatinib; Sorafenib; Oncology; Renal cell carcinoma; Bevacizumab; Internal medicine; Tyrosine-kinase inhibitor; Nivolumab; PI3K/AKT/mTOR pathway; Cancer; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001407343,0.0007311455,0.002066881,0.001459475,0.0002140989,0.001493832,0.0009564055,0.000936666,0.003155843],"category_scores_gemma":[0.002128009,0.0002273241,0.0007554639,0.001645652,0.0004447312,0.001898726,0.0007056039,0.00143024,0.0009885719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007421474,"about_ca_system_score_gemma":0.001802261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007115555,"about_ca_topic_score_gemma":0.001325748,"domain_scores_codex":[0.999391,0.0001489104,0.0001421159,0.00007573113,0.0002008252,0.00004133565],"domain_scores_gemma":[0.9985581,0.0006351332,0.0003273284,0.00002784797,0.0003764188,0.00007520278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001196771,0.00003801625,0.0002337108,0.04889178,0.0002087573,0.0001778758,0.00006521059,0.0003697013,0.0006052003,0.001744788,0.04148091,0.9060643],"study_design_scores_gemma":[0.0000582436,0.0001988849,0.001166429,0.02682816,0.0006344361,0.001573802,0.0001495221,0.0002437772,0.0003091055,0.001801493,0.9670073,0.00002874076],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001044388,0.9983536,0.0000881169,0.0007302908,0.0004058177,0.000005874709,0.0000160629,0.000006618594,0.0002892749],"genre_scores_gemma":[0.0006397163,0.99771,0.0001629435,0.0006616899,0.0006575033,0.000008307444,0.00002797176,0.000002230879,0.0001295951],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003155843,"threshold_uncertainty_score":0.01055741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2710818547800087,"score_gpt":0.4488700099819271,"score_spread":0.1777881552019184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}